SCHEMBL7841853

SCHEMBL7841853

NCCCCC1CCSS1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.61
TARDBP Q13148 2/20 0.61
HSD17B10 Q99714 2/20 0.56
CYP2C9 P11712 1/20 0.56
MEN1 O00255 1/20 0.56
NR1I2 O75469 1/20 0.56
ALDH1A1 P00352 1/20 0.56
LMNA P02545 1/20 0.56
POLB P06746 1/20 0.56
THRB P10828 1/20 0.56
TSHR P16473 1/20 0.56
ACHE P22303 1/20 0.56
APEX1 P27695 1/20 0.56
RECQL P46063 1/20 0.56
BLM P54132 1/20 0.56
PMP22 Q01453 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
SAE1 Q9UBE0 1/20 0.56
UBA2 Q9UBT2 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29249679 0.98 KMT2A (0.59) KMT2ATARDBPHSD17B10CYP2C9MEN1
SCHEMBL10424416 0.98 KMT2A (0.59) KMT2ATARDBPHSD17B10CYP2C9MEN1
SCHEMBL7706970 0.98 KMT2A (0.59) KMT2ATARDBPHSD17B10CYP2C9MEN1
SCHEMBL29263924 0.89 HSD17B10 (0.67) KMT2ATARDBPHSD17B10CYP2C9MEN1
SCHEMBL22140625 0.86 KMT2A (0.47) KMT2ATARDBPHSD17B10CYP2C9MEN1
SCHEMBL27519130 0.81 KMT2A (0.46) KMT2ATARDBPHSD17B10CYP2C9MEN1
Thioctic Acid SCHEMBL4902709 0.79 HSD17B10 (0.87) KMT2ATARDBPHSD17B10CYP2C9MEN1
Lipoic Acid, Alpha SCHEMBL4902712 0.79 HSD17B10 (0.87) KMT2ATARDBPHSD17B10CYP2C9MEN1
SCHEMBL18415398 0.79 KMT2A (0.61) KMT2ATARDBPHSD17B10CYP2C9MEN1
SCHEMBL24359895 0.78 HSD17B10 (0.56) KMT2ATARDBPHSD17B10CYP2C9MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109384776-A A kind of 5-fluor-uracil derivative and its preparation method and application 南京友怡医药科技有限公司 2019-02-26 CN claimed
US-20230244141-A1 PHOTOCURABLE COMPOSITION AND METHOD FOR PRODUCING SEMICONDUCTOR DEVICE NISSAN CHEMICAL CORPORATION (JP) 2023-08-03 US disclosed
US-20230244141-A1 PHOTOCURABLE COMPOSITION AND METHOD FOR PRODUCING SEMICONDUCTOR DEVICE NISSAN CHEMICAL CORPORATION (JP) 2023-08-03 US disclosed
US-11681223-B2 Photocurable composition and method for producing semiconductor device NISSAN CHEMICAL CORPORATION (JP) 2023-06-20 US disclosed
US-11681223-B2 Photocurable composition and method for producing semiconductor device NISSAN CHEMICAL CORPORATION (JP) 2023-06-20 US disclosed
US-20190171101-A1 PHOTOCURABLE COMPOSITION AND METHOD FOR PRODUCING SEMICONDUCTOR DEVICE NISSAN CHEMICAL CORPORATION (JP) 2019-06-06 US disclosed
US-6313164-B1 TO ENHANCE THE ACTIVITY OF GLUTATHIONE RECLUCTASE; FOR THERAPY AND PROPHYLAXIS OF CARTARACTS SANKYO COMPANY, LIMITED (JP) 2001-11-06 US disclosed
EP-1070710-A2 Dithiolan derivatives, their preparation and their therapeutic effect Sankyo Company Limited (JP) 2001-01-24 EP disclosed
US-6013663-A CATARACT THERAPY OR PREVENTION SANKYO COMPANY, LIMITED (JP) 2000-01-11 US disclosed
EP-0869126-A1 Dithiolan derivatives, their preparation and their therapeutic effect Sankyo Company Limited (JP) 1998-10-07 EP disclosed